We are not afraid to go boldly into diseases and conditions for which few or no effective treatments have been developed. We love the challenge and accept the responsibility.
Our Programs
M. M. Al Malki et al. BloodAdvances 5, 2650-2659 (2021).
S. G. Holtan et al. Blood 140,LBA-4-LBA-4 (2022).
D. Wintjens et al. J of Crohn's and Colitis 15, 391-400(2020).
Tsai et al. Clin Gastroenterology andHepatology 19.10 (2021): 2031-2045.
D. Gleeson et al. Gut 60.12(2011): 1611-1629.
Source: Johns Hopkins School of Medicine
Source: American Autoimmune Related Diseases Association (AARDA)
Contact Us
We are pursuing breakthrough innovation in the spaces of autoimmunity and inflammation with a world-class team aiming to change the way devastating diseases are treated.
Get in Touch